Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Washington University School of Medicine
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01877551
First received: June 11, 2013
Last updated: May 20, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2018
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)